Tyche Industries [TYCHE] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Tyche Industries

BSE
Loading...

Aarti Drugs

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Tyche Industries wins in 12 metrics, Aarti Drugs wins in 8 metrics, with 0 ties. Tyche Industries appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTyche IndustriesAarti DrugsBetter
P/E Ratio (TTM)12.0123.66Tyche Industries
Price-to-Book Ratio0.993.26Tyche Industries
Debt-to-Equity Ratio0.0044.92Tyche Industries
PEG Ratio-1.100.37Tyche Industries
EV/EBITDA5.9517.07Tyche Industries
Profit Margin (TTM)19.33%7.80%Tyche Industries
Operating Margin (TTM)11.77%10.11%Tyche Industries
EBITDA Margin (TTM)11.77%10.11%Tyche Industries
Return on Equity9.08%12.28%Aarti Drugs
Return on Assets (TTM)8.42%6.53%Tyche Industries
Free Cash Flow (TTM)$78.21M$674.22MAarti Drugs
Dividend Yield3.84%0.22%Tyche Industries
1-Year Return-21.30%-4.79%Aarti Drugs
Price-to-Sales Ratio (TTM)2.341.84Aarti Drugs
Enterprise Value$635.27M$50.47BAarti Drugs
EV/Revenue Ratio1.012.08Tyche Industries
Gross Profit Margin (TTM)68.87%36.77%Tyche Industries
Revenue per Share (TTM)$62$265Aarti Drugs
Earnings per Share (Diluted)$11.91$20.63Aarti Drugs
Beta (Stock Volatility)0.180.12Aarti Drugs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Tyche Industries vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Tyche Industries
Aarti Drugs
Tyche Industries Stock Overview | Aarti Drugs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Tyche Industries-0.73%4.95%4.61%-1.35%0.35%-25.64%
Aarti Drugs0.73%4.61%0.24%1.59%41.06%7.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Tyche Industries-21.30%2.55%-47.15%160.00%585.85%427.68%
Aarti Drugs-4.79%-0.89%-50.06%219.30%2,690.01%2,872.19%

News Based Sentiment: Tyche Industries vs Aarti Drugs

Tyche Industries

News based Sentiment: NEGATIVE

September brought a mixed bag of results for Tyche Industries, with revenue growth offset by declining profits and a negative stock performance. The fluctuating valuation grade and bearish market trends suggest continued challenges for the company, making it a risky investment in the short term. The upcoming earnings report will be critical.

View Tyche Industries News Sentiment Analysis

Aarti Drugs

News based Sentiment: POSITIVE

Aarti Drugs reported substantial profit growth in both Q1FY26 and FY2025, coupled with increased institutional interest from Mutual Funds. While shareholding changes and recent price volatility exist, the overall narrative points towards a strengthening investment case.

View Aarti Drugs News Sentiment Analysis

Performance & Financial Health Analysis: Tyche Industries vs Aarti Drugs

MetricTYCHEAARTIDRUGS
Market Information
Market Cap i₹1.47B₹44.55B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i3,469201,942
90 Day Avg. Volume i3,099187,563
Last Close₹143.00₹491.60
52 Week Range₹129.10 - ₹224.50₹312.00 - ₹564.05
% from 52W High-36.30%-12.84%
All-Time High₹349.90 (Aug 17, 2020)₹1,026.95 (Oct 05, 2020)
% from All-Time High-59.13%-52.13%
Growth Metrics
Quarterly Revenue Growth-0.18%0.06%
Quarterly Earnings Growth-0.11%0.62%
Financial Health
Profit Margin (TTM) i0.19%0.08%
Operating Margin (TTM) i0.12%0.10%
Return on Equity (TTM) i0.09%0.12%
Debt to Equity (MRQ) i0.0044.92
Cash & Liquidity
Book Value per Share (MRQ)₹144.76₹149.84
Cash per Share (MRQ)₹82.13₹2.48
Operating Cash Flow (TTM) i₹112.96M₹2.83B
Levered Free Cash Flow (TTM) i₹124.07M₹1.68B
Dividends
Last 12-Month Dividend Yield i3.84%0.22%
Last 12-Month Dividend i₹5.50₹1.00

Valuation & Enterprise Metrics Analysis: Tyche Industries vs Aarti Drugs

MetricTYCHEAARTIDRUGS
Price Ratios
P/E Ratio (TTM) i12.0123.66
Forward P/E i24.7515.02
PEG Ratio i-1.100.37
Price to Sales (TTM) i2.341.84
Price to Book (MRQ) i0.993.26
Market Capitalization
Market Capitalization i₹1.47B₹44.55B
Enterprise Value i₹635.27M₹50.47B
Enterprise Value Metrics
Enterprise to Revenue i1.012.08
Enterprise to EBITDA i5.9517.07
Risk & Other Metrics
Beta i0.180.12
Book Value per Share (MRQ) i₹144.76₹149.84

Financial Statements Comparison: Tyche Industries vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TYCHEAARTIDRUGS
Revenue/Sales i₹127.00M₹5.91B
Cost of Goods Sold i₹39.53M₹3.73B
Gross Profit i₹87.47M₹2.17B
Research & Development iN/AN/A
Operating Income (EBIT) i₹14.95M₹593.60M
EBITDA i₹37.14M₹743.90M
Pre-Tax Income i₹32.60M₹511.10M
Income Tax i₹8.28M₹-28.60M
Net Income (Profit) i₹24.32M₹539.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TYCHEAARTIDRUGS
Cash & Equivalents i₹39.77M₹45.77M
Total Current Assets i₹1.21B₹13.38B
Total Current Liabilities i₹96.25M₹8.37B
Long-Term Debt i₹0₹2.86B
Total Shareholders Equity i₹1.37B₹13.69B
Retained Earnings i₹1.19B₹12.40B
Property, Plant & Equipment i₹68.16M₹27.03M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TYCHEAARTIDRUGS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTYCHEAARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i3,469201,942
Average Daily Volume (90 Day) i3,099187,563
Shares Outstanding i10.25M91.27M
Float Shares i2.94M39.04M
% Held by Insiders i0.71%0.60%
% Held by Institutions i0.00%0.11%

Dividend Analysis & Yield Comparison: Tyche Industries vs Aarti Drugs

MetricTYCHEAARTIDRUGS
Last 12-Month Dividend i₹5.50₹1.00
Last 12-Month Dividend Yield i3.84%0.22%
3-Year Avg Annual Dividend i₹3.00₹1.00
3-Year Avg Dividend Yield i1.41%0.23%
3-Year Total Dividends i₹9.00₹3.00
Ex-Dividend DateSep 19, 2025Feb 04, 2025